【摘要】：目的：旨在通過觀察三妙丸加減治療濕熱下注型HR-HPV感染的臨床療效,評價其療效,以尋求一種有效治療HR-HPV感染的中藥組方,從而防治宮頸癌的發(fā)生。 方法：選取符合納入標準的宮頸濕熱下注型HR-HPV持續(xù)感染患者30例,根據(jù)患者先后就診順序分為治療組、陽性藥物對照組,每個組收集病例15例。根據(jù)中醫(yī)藥治療本病的特點,結合臨床經(jīng)驗,將4周定為1個療程,連續(xù)使用三個療程后評價其療效。觀察兩組病例治療前后癥狀的改善情況,并通過HCⅡ檢測的變化,進行治療前后自身對比和兩組間對照。 結果：1、治療前后,治療組HPV轉陰14例,陽性藥物對照組HPV轉陰5例,兩組HPV轉陰率比較無顯著的統(tǒng)計學差異,但治療組轉陰率高于對照組。 2、治療前后,治療組與陽性藥物對照組總有效率分別為：治療組痊愈率60%,有效率100%；對照組痊愈率26.7%,有效率86.7%。兩組比較無顯著的統(tǒng)計學差異。但治療組痊愈率及總有效率皆高于對照組。 結論：運用三妙丸加減治療濕熱下注型HR-HPV感染患者,臨床療效確切。此方不僅可以使患者的自覺帶下和體征及舌脈等情況得到改善,還可以明顯降低HPV病毒負荷量值,且安全可靠。
[Abstract]:Objective: to observe the clinical efficacy of Sanmiao Pill in the treatment of damp-heat betting type HR-HPV infection and to evaluate its efficacy in order to find an effective prescription for the treatment of HR-HPV infection and to prevent the occurrence of cervical cancer. Methods: thirty patients with persistent cervix dampness and heat betting HR-HPV infection were selected and divided into treatment group (n = 15) and positive drug control group (n = 15). According to the characteristics of TCM treatment, combined with clinical experience, 4 weeks as a course of treatment, continuous use of three courses of treatment to evaluate its efficacy. The improvement of symptoms before and after treatment was observed, and the changes of HC 鈪，

本文編號：2166497